Supernus Pharmaceuticals

Supernus Pharmaceuticals

SUPN· Manufacturing· Fiscal year ends in December

CEO pay in FY2025Stock +37.4% in FY2025

Jack A. Khattar is the CEO of Supernus Pharmaceuticals and was paid $15.5M in FY2025 (Dec).

Pay$100 in the stock at the end of FY20 → $158
CEO pay is from each Supernus Pharmaceuticals proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Executives5

See all
  1. 1Jack A. KhattarFY2025
  2. 2Timothy C. DecFY2025
  3. 3Jonathan Rubin, MDFY2025
  4. 4Padmanabh P. Bhatt, Ph.D.FY2025
  5. 5Frank MottolaFY2025

Named executives and their total pay, from the Summary Compensation Table of the latest proxy.

Pay

See all

Supernus Pharmaceuticals paid its 5 named executives $21.6M in total in FY2025 (Dec). CEO Jack A. Khattar was paid $15.5M of that.

Name
Jack A. KhattarChief Executive Officer, President & Secretary
Timothy C. DecSenior Vice President, Chief Financial OfficerNot disclosed
Jonathan Rubin, MDSenior Vice President, Chief Medical Officer Research and Development
Padmanabh P. Bhatt, Ph.D.Senior Vice President, Intellectual Property, Chief Scientific OfficerNot disclosed
Frank MottolaSenior Vice President, Chief Technical Operations OfficerNot disclosed

of each named executive, from the Summary Compensation Table of each proxy.

Peers16

See all

The FY2025 (Dec) proxy of Supernus Pharmaceuticals names 16 peer companies for pay. Among Supernus Pharmaceuticals and these peers, CEO pay was 2nd highest of 5 and total shareholder return was the highest of 5.

2nd highest of 5in Supernus Pharmaceuticals and its pay peers, FY2025 (Dec) by CEO pay:

$7.9M$23.3M

1st highest of 5in Supernus Pharmaceuticals and its pay peers, FY2025 (Dec) by total shareholder return:

$17$198

The comes from the company's proxy. CEO pay and of each company come from its own Pay versus Performance table for the same fiscal year.

Board3

See all
  • Frederick M. HudsonDirector · 15 yr on the boardIndependentCEO and Compensation, Directors and Audit (Chair)—Paid as an executive
  • Georges Gemayel, Ph.D.Director · 10 yr on the boardIndependentCEO and Compensation (Chair), Directors and Audit, Governance and Nominating, Science—Paid as an executive
  • Bethany SensenigDirector · 2 yr on the boardIndependentDirectors and Audit—Paid as an executive

The board of the latest proxy (FY2025).

Activity

Filings6

See all
Proxy statementDEF 14AApr 30, 2026FY2025
Annual report10-KMar 2, 2026FY2025
Proxy statementDEF 14AApr 30, 2025FY2024
Annual report10-KFeb 25, 2025FY2024
Proxy statementDEF 14AApr 29, 2024FY2023
Annual report10-KFeb 27, 2024FY2023
For the press:Download CSVDownload PNGHow to use our data